Using mouse models, Dr. Marco Bortolato and his lab showed in Molecular Psychiatry that CELSR3, a high-confidence risk gene for Tourette syndrome, leads to tic-like behaviors by altering the distribution of dopamine D3 receptors. These data point to D3 receptors as a promising therapeutic target in Tourette syndrome.
